Masonia Traylor folded into a ball in the corner of the patient room. "No," the 23-year-old screamed, over and over again. She was HIV-positive. It came as a surprise to the now 38-year-old from ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

People infected with HIV must take antiretroviral drugs for life. But promising trials using engineered antibodies suggest that "functional cures" may be in reach. When you purchase through links on ...

1,994 dogs representing 201 breeds will compete at the 2025 National Dog Show Presented by Purina, with the event set to air on Thanksgiving – Thursday, November 27 – at 12 p.m. ET on NBC and Peacock.

To date, only seven people worldwide have been considered cured of HIV infection. Now, a study from the Federal University of São Paulo (UNIFESP), published in August, has reignited hope by achieving ...

Not every dog craves hours of walking or constant entertainment. For anyone seeking a loyal, low-maintenance companion who’s happy to lounge beside you while you work or watch your favorite series, ...

Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a secondhand high. Called “bluetoothing,” the gruesome movement is fueling a wave of new HIV ...

Everybody knows that dogs can learn to associate specific spoken words with objects that look a certain way. A groundbreaking new study, however, shows that some gifted dogs can also match given ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...